Novartis (NVS) Stock Price
$129.8 1%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
8 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Novartis, AI stock picks, stock alerts and much more.
NVS AI Stock Analysis
AI stock analysis for NVS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Novartis (NVS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Novartis (NVS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novartis (NVS), currently trading at $129.8, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NVS
-
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide.
-
Symbol
NVS
-
Market
NYSE
-
Industry
Drug Manufacturers - General
-
Market Cap
251.2B
Similar Stocks
 |
Johnson & Johnson JNJ |
$178.4 0.2% |
6 |
 |
Eli Lilly and Company LLY |
$726.9 2.2% |
7 |
 |
Pfizer PFE |
$24.88 1.4% |
4 |
 |
AbbVie ABBV |
$212.5 0.2% |
7 |
 |
Merck & Company MRK |
$84.71 0.8% |
5 |
News
NVS Alternative Data
Web Traffic
Novartis receives an estimated 1.7M monthly visitors to novartis.com.
-
Web Traffic
1666662
-
Change from Previous Month
72.5%
-
3 Month Change
54.4%
-
YoY Change
54.4%
Twitter Followers
Novartis has 292,489 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.
-
Twitter Followers
292489
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Facebook Engagement
Novartis has engaged 341 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
341
-
Daily Change
6.1%
-
1 Month Change
179.5%
-
3 Month Change
54.5%
-
YoY Change
54.5%
Instagram Followers
Novartis has 124,012 Instagram Followers on its main Instagram account, up by 0.2% over the last month.
-
Instagram Followers
124012
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Youtube Subscribers
Novartis has 49,200 subscribers on its main Youtube channel, up by 1.7% over the last month.
-
Youtube Subscribers
49200
-
Daily Change
0.2%
-
1 Month Change
1.7%
-
3 Month Change
6%
-
YoY Change
6%
LinkedIn Followers
4,299,627 are following Novartis on LinkedIn, up by 1.2% over the last month.
-
LinkedIn Followers
4299627
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
3.4%
-
YoY Change
3.4%
Job Postings
Novartis currenly has an estimated 1,000 open job postings.
-
Job Postings
1000
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
50%
-
YoY Change
50%
LinkedIn Employees
According to LinkedIn, Novartis has 80,214 employees, up by 0.5% over the last month.
-
LinkedIn Employees
80214
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.6%
-
YoY Change
1.6%
Reddit Mentions
Novartis has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Novartis is 73 out of 100 (bullish).
-
Business Outlook
73
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Novartis was mentioned 10 times in the news yesterday.
-
News Mentions
10
-
Daily Change
41.2%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
NVS Financials
NVS Key Metrics
-
Total Revenue
$13.6B
-
Net Income
$3.6B
-
Earnings per Share
$1.83
-
Free cash flow
$2.2B
-
EBITDA
$5.8B
-
EBITDA Ratio
0.42812
-
Total Assets
$99.9B
NVS 2-year Revenue & Income
NVS 2-year Free Cash Flow
NVS Technicals
NVS SMA
NVS RSI
FAQ
What's the current price of Novartis (NVS) Stock?
The price of an Novartis (NVS) share is $129.8.
What's the market cap of Novartis?
The current market cap of Novartis is 251.2B.
Should I buy or sell NVS?
Novartis shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Novartis is better viewed as a hold or accumulate position while waiting for further developments.
Is Novartis a good investment?
The current analysis of Novartis' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Novartis' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Novartis (NVS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Novartis stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Novartis (NVS) that investors often compare it to?
Novartis (NVS) is often compared to similar stocks such as Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie and Merck & Company.
What is the forecast for Novartis' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novartis' stock price to be around $136.5 in 2026. Starting from the current price of $129.8, this represents a 5.2% change in price, indicating a bullish outlook for the stock.
How to buy Novartis (NVS) Stock?
Novartis stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novartis shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.